These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 10688981

  • 1. Inhibitory effect of orally administered donepezil hydrochloride (E2020), a novel treatment for Alzheimer's disease, on cholinesterase activity in rats.
    Kosasa T, Kuriya Y, Matsui K, Yamanishi Y.
    Eur J Pharmacol; 2000 Feb 18; 389(2-3):173-9. PubMed ID: 10688981
    [Abstract] [Full Text] [Related]

  • 2. Effect of donepezil hydrochloride (E2020) on basal concentration of extracellular acetylcholine in the hippocampus of rats.
    Kosasa T, Kuriya Y, Matsui K, Yamanishi Y.
    Eur J Pharmacol; 1999 Sep 10; 380(2-3):101-7. PubMed ID: 10513568
    [Abstract] [Full Text] [Related]

  • 3. Effect of donepezil hydrochloride (E2020) on extracellular acetylcholine concentration in the cerebral cortex of rats.
    Kosasa T, Kuriya Y, Yamanishi Y.
    Jpn J Pharmacol; 1999 Oct 10; 81(2):216-22. PubMed ID: 10591480
    [Abstract] [Full Text] [Related]

  • 4. Inhibitory effects of donepezil hydrochloride (E2020) on cholinesterase activity in brain and peripheral tissues of young and aged rats.
    Kosasa T, Kuriya Y, Matsui K, Yamanishi Y.
    Eur J Pharmacol; 1999 Dec 10; 386(1):7-13. PubMed ID: 10611458
    [Abstract] [Full Text] [Related]

  • 5. Comparison of inhibitory activities of donepezil and other cholinesterase inhibitors on acetylcholinesterase and butyrylcholinesterase in vitro.
    Ogura H, Kosasa T, Kuriya Y, Yamanishi Y.
    Methods Find Exp Clin Pharmacol; 2000 Oct 10; 22(8):609-13. PubMed ID: 11256231
    [Abstract] [Full Text] [Related]

  • 6. Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitors.
    Jann MW, Shirley KL, Small GW.
    Clin Pharmacokinet; 2002 Oct 10; 41(10):719-39. PubMed ID: 12162759
    [Abstract] [Full Text] [Related]

  • 7. Comparison of donepezil-, tacrine-, rivastigmine- and metrifonate-induced central and peripheral cholinergically mediated responses in the rat.
    Dronfield S, Egan K, Marsden CA, Green AR.
    J Psychopharmacol; 2000 Oct 10; 14(3):275-9. PubMed ID: 11106308
    [Abstract] [Full Text] [Related]

  • 8. Central and peripheral activity of cholinesterase inhibitors as revealed by yawning and fasciculation in rats.
    Ogura H, Kosasa T, Kuriya Y, Yamanishi Y.
    Eur J Pharmacol; 2001 Mar 10; 415(2-3):157-64. PubMed ID: 11274994
    [Abstract] [Full Text] [Related]

  • 9. Effect of 3-[1-(phenylmethyl)-4-piperidinyl]-1-(2,3,4,5-tetrahydro-1H-1-benzazepin-8-yl)-1-propanone fumarate, a novel acetylcholinesterase inhibitor, on spatial cognitive impairment induced by chronic cerebral hypoperfusion in rats.
    Xu AJ, Chen Z, Yanai K, Huang YW, Wei EQ.
    Neurosci Lett; 2002 Oct 04; 331(1):33-6. PubMed ID: 12359317
    [Abstract] [Full Text] [Related]

  • 10. Comparative studies of huperzine A, E2020, and tacrine on behavior and cholinesterase activities.
    Cheng DH, Tang XC.
    Pharmacol Biochem Behav; 1998 Jun 04; 60(2):377-86. PubMed ID: 9632220
    [Abstract] [Full Text] [Related]

  • 11. Effects of huperzine A on acetylcholinesterase isoforms in vitro: comparison with tacrine, donepezil, rivastigmine and physostigmine.
    Zhao Q, Tang XC.
    Eur J Pharmacol; 2002 Nov 29; 455(2-3):101-7. PubMed ID: 12445575
    [Abstract] [Full Text] [Related]

  • 12. Pharmacological characterization of orally active cholinesterase inhibitory activity of Prunus persica L. Batsch in rats.
    Suh SJ, Koo BS, Jin UH, Hwang MJ, Lee IS, Kim CH.
    J Mol Neurosci; 2006 Nov 29; 29(2):101-7. PubMed ID: 16954599
    [Abstract] [Full Text] [Related]

  • 13. Neurochemical effects of 3-[1-(phenylmethyl)-4-piperidinyl]-1-(2,3,4,5-tetrahydro-1H-1-b enzazepin-8-yl)-1-propanone fumarate (TAK-147), a novel acetylcholinesterase inhibitor, in rats.
    Hirai K, Kato K, Nakayama T, Hayako H, Ishihara Y, Goto G, Miyamoto M.
    J Pharmacol Exp Ther; 1997 Mar 29; 280(3):1261-9. PubMed ID: 9067312
    [Abstract] [Full Text] [Related]

  • 14. Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer's disease.
    Kaasinen V, Någren K, Järvenpää T, Roivainen A, Yu M, Oikonen V, Kurki T, Rinne JO.
    J Clin Psychopharmacol; 2002 Dec 29; 22(6):615-20. PubMed ID: 12454562
    [Abstract] [Full Text] [Related]

  • 15. Comparative effects of huperzine A, donepezil and rivastigmine on cortical acetylcholine level and acetylcholinesterase activity in rats.
    Liang YQ, Tang XC.
    Neurosci Lett; 2004 May 06; 361(1-3):56-9. PubMed ID: 15135892
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics and drug interactions of cholinesterase inhibitors administered in Alzheimer's disease.
    Crismon ML.
    Pharmacotherapy; 1998 May 06; 18(2 Pt 2):47-54; discussion 79-82. PubMed ID: 9543465
    [Abstract] [Full Text] [Related]

  • 17. Potencies and selectivities of inhibitors of acetylcholinesterase and its molecular forms in normal and Alzheimer's disease brain.
    Rakonczay Z.
    Acta Biol Hung; 2003 May 06; 54(2):183-9. PubMed ID: 14535624
    [Abstract] [Full Text] [Related]

  • 18. Effects of 3-[1-(phenylmethyl)-4-piperidinyl]-1-(2,3,4,5-tetrahydro-1 -H-1-benzazepin-8-yl)-1-propanone fumarate (TAK-147), a novel acetylcholinesterase inhibitor, on impaired learning and memory in animal models.
    Miyamoto M, Takahashi H, Kato K, Hirai K, Ishihara Y, Goto G.
    J Pharmacol Exp Ther; 1996 Jun 06; 277(3):1292-304. PubMed ID: 8667190
    [Abstract] [Full Text] [Related]

  • 19. Effects of novel tacrine-related cholinesterase inhibitors in the reversal of 3-quinuclidinyl benzilate-induced cognitive deficit in rats--Is there a potential for Alzheimer's disease treatment?
    Misik J, Korabecny J, Nepovimova E, Kracmarova A, Kassa J.
    Neurosci Lett; 2016 Jan 26; 612():261-268. PubMed ID: 26708634
    [Abstract] [Full Text] [Related]

  • 20. Effect of oral administration of zanapezil (TAK-147) for 21 days on acetylcholine and monoamines levels in the ventral hippocampus of freely moving rats.
    Hatip-Al-Khatib I, Iwasaki K, Yoshimitsu Y, Arai T, Egashira N, Mishima K, Ikeda T, Fujiwara M.
    Br J Pharmacol; 2005 Aug 26; 145(8):1035-44. PubMed ID: 15951830
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.